Aaron Cranston

3.8k citations
42 papers · 2.9k · 2 hit papers · h-index 18

Impact in

  • Oncology top 1%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways
    • DNA Repair Mechanisms
    • CRISPR and Genetic Engineering

Papers in

    • DNA Repair Mechanisms 9
    • Ubiquitin and proteasome pathways 4
    • PARP inhibition in cancer therapy 10
    • Cancer-related Molecular Pathways 5

Aaron Cranston

39 papers receiving 2.8k citations

Aaron Cranston's Hit Papers

4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1 2008 · 501 citations
5010+6+12Years since publication250500750

Peers

Aaron Cranston
Comparison fields: 5 of 93
  • Oncology 1.8k
  • Molecular Biology 1.7k
  • Cancer Research 298
  • Pathology and Forensic Medicine 310
  • Reproductive Medicine 134
Replace Shaozhen Xie with:
Shaozhen Xie United States
Antonella Papa United States
Chouhei Sakakura Japan
Sohye Kang United States
Daniel Nava Rodrigues United Kingdom
Heng‐Huan Lee United States
Seth A. Ettenberg United States
Sara Ricardo Portugal
Rozita Bagheri‐Yarmand United States
Alicia S. Chung United States
Aaron Cranston relative to Shaozhen Xie United States Shaozhen Xie's profile →
Citations per field
00.5×2×3.1×
Shaozhen Xie · 1×
Citations per year

Countries citing papers authored by Aaron Cranston

Since Specialization
Citations

This map shows the geographic impact of Aaron Cranston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Cranston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Cranston more than expected).

Fields of papers citing papers by Aaron Cranston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Cranston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Cranston. The network helps show where Aaron Cranston may publish in the future.

Co-authors

The 25 scholars most cited alongside Aaron Cranston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aaron Cranston Line = papers co-authored together Aaron Cranston links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Hit paper breakdown →
2008790
2
4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
Hit paper breakdown →
2008501
3 2012398
4 1998163
5
Apoptosis induced by overexpression of hMSH2 or hMLH1.
1999162
6 200997
7
Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.
200082
8 199976
9 200668
10 199766
11 201660
12 200458
13 201057
14 200545
15 200141
16
Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.
200340
17 200631
18 200522
19 199915
20 200014

About Aaron Cranston

Aaron Cranston is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Genetics and Endocrinology, Diabetes and Metabolism, having authored 42 papers that have together received 2.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), DNA Repair Mechanisms (9 papers), Genetic factors in colorectal cancer (9 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer-related Molecular Pathways (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Genomics and Diagnostics (4 papers) and BRCA gene mutations in cancer (3 papers). The work is most often cited by research in Oncology (1.8k citations), Molecular Biology (1.7k citations), Cancer Research (298 citations), Pathology and Forensic Medicine (310 citations) and Reproductive Medicine (134 citations). Aaron Cranston has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Alan Lau, Mark J. O’Connor, Niall M.B. Martin, Richard Fishel, Sven Rottenberg, Jos Jonkers, Janneke E. Jaspers, Ariena Kersbergen, Serge A.L. Zander and Piet Borst. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, The Journal of Experimental Medicine, Human Gene Therapy and Cold Spring Harbor Symposia on Quantitative Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact